NanoVibronix

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. The firm's products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, Europe, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Elmsford, NY.

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its PainShield Plus and PainShield Monthly Kit products have been added to the Federal Supply Schedule (FSS) through a service disabled veteran organization. With these recent additions, NanoVibronix is able to make three of its leading products available

NanoVibronix Adds Additional Product to Federal Supply Schedule

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has received the publication of Guidance from the National Institute for Health and Care Excellence (NICE) with recommendations of the company's UroShield device. The Guidance states that UroShield has the potential to provide significant patient and healthcare system

NanoVibronix Advances Efforts to Achieve NHS Approval

Imperial Petroleum

The Metals Co

Can these penny stocks continue to make moves next month? The post Best Penny Stocks to Buy Now?

Best Penny Stocks to Buy Now? Here's 3 to Watch in April 2022

Adagio Therapeutics

Direct Digital Holdings

Geron

Sonoma Pharmaceuticals

Vyant Bio

Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

NanoVibronix Inc's (NASDAQ: NAOV) PainGuard and UroGuard have been approved by Health Canada / Santé Canada as licensed medical devices. The products are offered as private label products through Ideal Medical International Limited.

Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the Company's PainGuard and UroGuard, offered as private label products through Ideal Medical International Limited, have been approved by Health Canada / Santé Canada as licensed medical devices. The license issued by Health Canada allows Ideal Medical International Limited

NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a Provider Agreement with EZ Health Care. Under the terms of the agreement, NanoVibronix has been added to the EZ Workers' Comp Network, making it easier for healthcare providers to file claims and be reimbursed when prescribing PainShield for patients being tr

NanoVibronix Added an Additional National Payer Network in Workers' Compensation Market

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed an International Marketing, Sales and Clinical Management Agreement with Medtech Solutions Group (“MTSG”), a leader in the commercialization of healthcare technologies. The agreement allows MTSG to commercialize UroShield® and PainShield® throughout Europe, exc

NanoVibronix Extends Reach of UroShield and PainShield through MTSG's International Network

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has filed three U.S. patent applications with the U.S. Patent & Trademark Office related to its SAW technology and indwelling medical devices to protect targeted new product launches and improvements to existing medical devices. Brian Murphy, Chief Executive Officer of

NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced its board of directors has appointed Ms. Aurora (Rori) Cassirer and Ms. Maria (Lulu) Schroeder to serve as independent directors effective today. Ms. Cassirer will serve on the compensation and nominating and governance Committees and Ms. Schroeder will serve on the audit Com

NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it will be featured as a presenting company at the H.C. Wainwright BioConnect Virtual Conference to be held January 10-13, 2022. Brian Murphy, Chief Executive Officer of NanoVibronix, will provide an overview of the Company's business during the presentation. If you are an in

NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that Delta Medical, LLC, a Service-Disabled Veteran-Owned Small Business (“SDVOSB”) has been added to the company's eco-system of distribution channels to help drive sales of its PainShield products to Veteran's Administration hospitals and healthcare facilities. Brian Murphy

NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has signed an agreement with Applied Medical Solutions, LLC (“AMS”) for the sale and distribution of its PainShield products to Veterans Administration facilities located throughout the United States. Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., commen

NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities

NanoVibronix Inc (NASDAQ: NAOV) has commenced sales in Europe by signing a distribution agreement with Medina Healthcare Ltd for UroShield and PainShield devices. UroShield is an ultrasound-based product designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI).

NanoVibronix, Medina Ink Distribution Pact For Ultrasound Devices In Europe

Elmsford, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc. (the “Company”) (NASDAQ: NAOV) announced today that the Company's Special Meeting of Stockholders, scheduled for 10:00 a.m. Eastern time today, December 21, 2021, has been adjourned to allow for more time for stockholders to vote due to a lack of quorum. The meeting has been scheduled to reconvene on December 29, 2021 at 10:00 a.m. Eastern time and will be held virtually online at www.virtualshareholdermeeting.com/NAOV2021SM2.

NanoVibronix Adjourns Special Meeting of Stockholders

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has commenced sales in Europe with the signing of a distribution agreement with Medina Healthcare Ltd (“Medina”) in Malta. Brian Murphy, Chief Executive Officer of NanoVibronix Inc., commented, "NanoVibronix have has already obtained regulatory approval to sell our ra

NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion

Visit the Company in Booth #1129 in the Exhibit Hall Visit the Company in Booth #1129 in the Exhibit Hall

NANOVIBRONIX TO SHOWCASE PAINSHIELD PRODUCTS AT 75TH ANNUAL WORKERS' COMPENSATION EDUCATIONAL CONFERENCE DECEMBER 12-15

Elmsford, NY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive interim results from an independent, real world patient study of its UroShield at Southampton University Health Sciences.

NanoVibronix Announces Encouraging Interim Results in Real World Patient Study of UroShield

Elmsford, NY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and  PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that sales of its Painshield device to the Veterans Administration (VA) has been accelerating.

NanoVibronix Announces Early Success in the Marketing of Painshield to Veteran's Administration Healthcare Providers

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today reported its financial results for the quarter ended September 30, 2021. Third Quarter Financial and Business Highlights Revenue of $499,000, an increase of 233% compared to the prior year period Introduced CBD gel for topical treatment of pain and in combination with PainShield, to product line-

NanoVibronix Reports Third Quarter 2021 Financial Results

Elmsford, NY, Oct. 28, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update and letter to shareholders from its Chief Executive Officer, Brian Murphy:

NanoVibronix CEO Brian Murphy Provides Business Update in Letter to Shareholders

Cinedigm

Seelos Therapeutics

Are these penny stocks on your October watchlist? The post Top Penny Stocks to Know in Mid-October 2021?

Top Penny Stocks to Know in Mid-October 2021? 3 to Watch

NanoVibronix Inc (NASDAQ:NAOV) has announced results from a randomized, double-blind study to evaluate the safety and effectiveness of the NanoVibronix PainShield. Related:   NanoVibronix Launches CBD-Based Product For Pain Management.

NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain

The stock price of NanoVibronix, Inc., (NASDAQ: NAOV) increased by over 25% during intraday today. This is why it happened.

NAOV Stock: Why It Substantially Increased Today

Study Finds PainShield Device is Safe and Effective in the Treatment of Tennis Elbow Study Finds PainShield Device is Safe and Effective in the Treatment of Tennis Elbow

News for NanoVibronix Stock (NAOV)